Patents by Inventor Eric Charles Meldrum

Eric Charles Meldrum has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120035245
    Abstract: The present invention relates to agents, and methods for identifying compounds, which agents and compounds result in the stabilization of mast cells, in particular that inhibit mast cell degranulation. In addition, the invention relates to compositions and methods for the use thereof in treating conditions that are characterized by mast cell degranulation and/or inflammation, including allergic rhinitis.
    Type: Application
    Filed: February 18, 2010
    Publication date: February 9, 2012
    Inventors: Richard Antonius Jozef Janssen, Anton De Groot, Annemarie Nicolette Lekkerkerker, Eric Charles Meldrum, Nicola Thompson
  • Publication number: 20120004160
    Abstract: The present invention relates to agents, and methods for identifying compounds, which agents and compounds result in the inhibition of the activation of macrophages. In addition, the invention relates to compositions and methods for the use thereof in treating conditions that are characterized by activation of macrophages including infections, allograft reactions, inflammation, allergic and autoimmune diseases, metabolic disease, cardiovascular disease, tissue injury, and cancer.
    Type: Application
    Filed: February 18, 2010
    Publication date: January 5, 2012
    Applicants: Glaxo Group Ltd., Bio-Focus DPI B.V.
    Inventors: Richard Antonius Jozef Janssen, Anton De Groot, Annemarie Nicolette Lekkerkerker, Eric Charles Meldrum, Nicola Thompson, Marion Catherine Dickson, Keith Paul Ray, Susan Heather Boyce
  • Publication number: 20110306655
    Abstract: The present invention relates to agents, and methods for identifying compounds, which agents and compounds result in the inhibition of the maturation of dendritic cells. In addition, the invention relates to compositions and methods for the use thereof in treating conditions that are characterized by maturation of dendritic cells including infections, allograft reactions, inflammation, allergic and autoimmune diseases, and cancer.
    Type: Application
    Filed: February 18, 2010
    Publication date: December 15, 2011
    Inventors: Richard Antonius Jozef Janssen, Anton De Groot, Annemarie Nicolette Lekkerkerker, Eric Charles Meldrum, Nicola Thompson, Dilniya Fattah